These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6432285)

  • 21. Gliclazide (diamicron) in metabolic and vascular treatment of diabetes mellitus.
    Forette B
    East Afr Med J; 1977 Oct; 54(10):579-81. PubMed ID: 608430
    [No Abstract]   [Full Text] [Related]  

  • 22. [Medium term effect (3 months) of hypoglycemic sulfamide treatment (gliclazide) on insulin secretion of the non-insulin dependent diabetic].
    Brogard JM; Pinget M; Leconte A; Dorner M
    Rev Med Interne; 1982 Dec; 3(4):379-87. PubMed ID: 6761818
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of short term hypoglycemic treatment with gliclazide and gliquidone on platelet function in patients with diabetes mellitus type II].
    Grzeszczak W; Strojek K
    Pol Tyg Lek; 1993 Apr; 48 Suppl 1():38-9. PubMed ID: 8516206
    [No Abstract]   [Full Text] [Related]  

  • 24. [Does hypoglycemic treatment with gliclazide and gliquidone affect platelet function in type II diabetic patients?].
    Strojek K; Bresler M; Gumprecht J; Grzeszczak W; Trautsolt W
    Pol Arch Med Wewn; 1993 Apr; 89(4):315-9. PubMed ID: 8351232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical trial with a new oral antidiabetic, gliclazid, in general practice (author's transl)].
    Villiger U
    Schweiz Rundsch Med Prax; 1982 Apr; 71(16):699-704. PubMed ID: 7050960
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug interactions of gliclazide and other sulfonylureas in protein binding in vitro and in hypoglycemic effect in rats.
    Fujii T; Nakamura K; Furukawa H; Watanabe M; Kuwashima J; Miyazaki H; Kawashima K; Kuzuya T
    Arzneimittelforschung; 1983; 33(11):1535-7. PubMed ID: 6686448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The "in vitro" effect of gliclazide, a new hypoglycemic agent, on normal human blood platelets].
    Vainer H; Verry M
    Thromb Res; 1974 Apr; 4(4):523-38. PubMed ID: 4215174
    [No Abstract]   [Full Text] [Related]  

  • 28. [Free radical scavenging activity of sulfonylureas: a clinical assessment of the effectiveness of gliclazide].
    Jennings PE; Belch JJ
    Ter Arkh; 2001; 73(4):27-31. PubMed ID: 11494442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gliclazide in the treatment of obese non-insulin dependent diabetic patients.
    Seshiah V; Venkataraman S; Suresh K
    J Assoc Physicians India; 1993 Jun; 41(6):367-8. PubMed ID: 8005974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison on sulphonylurea and insulin treatment on lipid levels in maturity-onset diabetic men and women.
    Berry EM; Bar-on H
    Isr J Med Sci; 1981 May; 17(5):384-7. PubMed ID: 7021470
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on the hypoglycaemic action of gliclazide, a sulphonyl-urea drug [proceedings].
    Furman BL; Musbah MO
    J Pharm Pharmacol; 1977 Dec; 29 Suppl():55P. PubMed ID: 22687
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiaggregatory activity of hypoglycaemic sulphonylureas.
    Siluk D; Kaliszan R; Haber P; Petrusewicz J; Brzozowski Z; Sut G
    Diabetologia; 2002 Jul; 45(7):1034-7. PubMed ID: 12136403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes mellitus--practical aspects: serial determination of plasma insulin levels is useful method of determining type of diabetes.
    D'Allessandro FM
    R I Med J (1976); 1982 Jun; 65(6):247-50. PubMed ID: 7051252
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of sulfonylureas and clofibrate on insulin receptors in cultured human lymphocytes.
    Zeng SF; Yokono K; Baba S
    Kobe J Med Sci; 1985 Aug; 31(4):169-82. PubMed ID: 3906258
    [No Abstract]   [Full Text] [Related]  

  • 35. [The adhesiveness of platelets and the alteration of retinal capillaries. An experimental study in streptozotocin-induced diabetic rats (author's transl)].
    Kojima K; Harada T; Suzuki M; Awaya S; Ichikawa H
    Nippon Ganka Gakkai Zasshi; 1979 Jun; 83(6):463-71. PubMed ID: 484386
    [No Abstract]   [Full Text] [Related]  

  • 36. A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.
    Charbonnel BH; Matthews DR; Schernthaner G; Hanefeld M; Brunetti P;
    Diabet Med; 2005 Apr; 22(4):399-405. PubMed ID: 15787663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gliclazide: the effects on lipids in type II diabetes.
    Delargy M; McGovern M; Johnson A; Tomkin GH
    Ir J Med Sci; 1985 Mar; 154(3):102-5. PubMed ID: 3997441
    [No Abstract]   [Full Text] [Related]  

  • 38. [Inhibitory effect of gliclazide on platelet adhesiveness and aggregation in alloxan diabetic rabbits (author's transl)].
    Kuwashima J; Tsuboi T; Komiya M; Fujitani B; Nakamura K; Maeda J; Kaneko H; Yoshida K; Shimizu M
    Yakugaku Zasshi; 1979 Jan; 99(1):59-64. PubMed ID: 430345
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect on platelet adhesiveness in diabetics after long-term treatment with a new oral hypoglycaemic agent, gliclazide.
    Rubinjoni Z; Turk Z; Coce F; Mustovic D; Maitre D; Skrabalo Z
    Curr Med Res Opin; 1978; 5(8):625-31. PubMed ID: 361347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Physiological and pharmacological aspects of fibrinolysis].
    Fearnley GR
    Clin Ter; 1971 May; 57(3):205-25. PubMed ID: 5110942
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.